Funded Startups in Goleta
Recent disclosed funding in Goleta spans 2020-10-27 (Apeel Sciences) through 2025-03-27 (Aeluma), with the newest entry at the 2025-03-27 mark.
Recent disclosed funding in Goleta spans 2020-10-27 (Apeel Sciences) through 2025-03-27 (Aeluma), with the newest entry at the 2025-03-27 mark. Size is concentrated at the top: Apeel Sciences’ $250M Series E (2021-08-18) dwarfs the next-largest disclosed amount of $30M (Apeel Sciences, 2020-10-27) and sits far above the rest of the Goleta rounds shown (e.g., $12M on 2025-03-27 for Aeluma; $12M on 2022-02-15 for KOS; $8M on 2023-07-25 for Transphorm).
The list also shows a tight sector and company cluster. Six of nine rows list “Agriculture and Farming” for Apeel Sciences (2021-08-18 at $250M; 2020-10-27 at $30M), while multiple hardware/electronics rounds remain smaller and spread out across 2022–2023 (e.g., Nexus Photonics $5M on 2022-05-02; Transphorm $8M on 2023-07-25). Stage labels are mixed: five of nine rows are “Series Unknown” (including Aeluma on 2025-03-27 at $12M; Vitamin Angels on 2023-12-06 at $300K; and Transphorm on 2023-07-25 at $8M), with only one “Series B” (True Digital Surgery $3M on 2023-08-16) and one “Series E” (Apeel Sciences $250M on 2021-08-18).
Most recent rounds
9 shownRelated listings
Frequently asked
What’s the largest disclosed Goleta round in this set, and how does it compare to the next-largest disclosed amount?
Apeel Sciences’ $250M Series E closed on 2021-08-18, and it dwarfs the next-largest disclosed amount of $30M from Apeel Sciences on 2020-10-27; no other disclosed entry in the table exceeds $30M (e.g., $12M for Aeluma on 2025-03-27 and $12M for KOS on 2022-02-15).
Are there company- or sector-concentrations that dominate the Goleta list?
Yes. Apeel Sciences appears twice in the rows shown (Agriculture and Farming) with $250M on 2021-08-18 and $30M on 2020-10-27, and it accounts for both of the largest disclosed amounts in the table; outside of that, electronics/hardware-linked entries (e.g., Nexus Photonics $5M on 2022-05-02 and Transphorm $8M on 2023-07-25) are comparatively smaller and more distributed across dates.
How clustered are the funding dates within the displayed window?
There’s a heavy concentration in the mid-period: five of nine rows fall between 2022-02-15 and 2023-12-06 (KOS $12M on 2022-02-15; Nexus Photonics $5M on 2022-05-02; True Digital Surgery $3M on 2023-08-16; Transphorm $8M on 2023-07-25; Vitamin Angels $300K on 2023-12-06). The oldest row is 2020-10-27 (Apeel Sciences $30M) and the most recent is 2025-03-27 (Aeluma $12M).
What stage/round-label mix stands out in this Goleta slice?
“Series Unknown” shows up in 5 of 9 rows (including Aeluma 2025-03-27 at $12M; Vitamin Angels 2023-12-06 at $300K; Transphorm 2023-07-25 at $8M; Nexus Photonics 2022-05-02 at $5M; and one Apeel Sciences row with an unspecified stage on 2020-10-27 at $30M). By contrast, distinct labeled stages visible here include Series E (Apeel Sciences, 2021-08-18 at $250M) and Series B (True Digital Surgery, 2023-08-16 at $3M).
Are there outliers worth flagging for diligence?
Apeel Sciences is the clear magnitude outlier: $250M on 2021-08-18 (Series E) is far above every other disclosed figure in the table, and even its own second disclosed round is $30M on 2020-10-27. On the low end, Vitamin Angels at $300K on 2023-12-06 (Series Unknown) is substantially smaller than the cluster of multi-million-dollar rounds like LaunchPoint EPS $630K on 2023-05-11, True Digital Surgery $3M on 2023-08-16, and Transphorm $8M on 2023-07-25.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.